Content about Harvard University

March 17, 2014

As part of research funded by a grant from the National Science Foundation, a recent study found that Google Flu Trend may not be all it's cracked up to be.

HOUSTON — As part of research funded by a grant from the National Science Foundation, a recent study found that Google Flu Trend may not be all it's cracked up to be. The study, published in the journal Science, also suggested that aggregated big data tools may have their faults.

January 10, 2014

Fewer than half of people who could benefit from the heart-health benefits of a daily low-dose aspirin take it, while many others take it when they shouldn't, the January 2014 Harvard Heart Letter reported Friday.

BOSTON — Fewer than half of people who could benefit from the heart-health benefits of a daily low-dose aspirin take it, while many others take it when they shouldn't, the January 2014 Harvard Heart Letter reported Friday.

October 25, 2013

L’Oréal USA honored the recipients of the 2013 L’Oréal USA Fellowships For Women in Science at an awards ceremony Thursday evening. Celebrating its 10th year, the program is a national initiative that annually recognizes and rewards five U.S.-based post-doctoral women researchers.

NEW YORK — L’Oréal USA honored the recipients of the 2013 L’Oréal USA Fellowships For Women in Science at an awards ceremony Thursday evening. Celebrating its 10th year, the program is a national initiative that annually recognizes and rewards five U.S.-based post-doctoral women researchers.

September 3, 2013

Over the last few years, many drug makers have offered coupons and co-payment-assistance programs as a way to reduce patients' out-of-pocket spending on medications, but a new study questions whether they really reduce spending in the long run and whether they're even legal.

NEW YORK — Over the last few years, many drug makers have offered coupons and co-payment-assistance programs as a way to reduce patients' out-of-pocket spending on medications, but a new study questions whether they really reduce spending in the long run and whether they're even legal.

January 7, 2013

Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch.

BOSTON — Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch

"Topical pain relievers can be very helpful for the more superficial joints like the knees, ankles, feet, elbows and hands," stated Rosalyn Nguyen, a clinical instructor in physical medicine and rehabilitation at Harvard Medical School. "In those areas, the medication can penetrate closer to the joint."

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.

May 29, 2012

The most effective way to get patients to stick with their medication regimens all the way through their therapy, it turns out, is to give the job to community pharmacists. That means giving them time and adequate compensation to do what they do best: counsel and monitor patients, one-on-one.

The most effective way to get patients to stick with their medication regimens all the way through their therapy, it turns out, is to give the job to community pharmacists. That means giving them time and adequate compensation to do what they do best: counsel and monitor patients, one-on-one.

Behind the common-sense conclusion that pharmacists can be the most effective resource for improving patients' drug adherence rates is a new study from CVS Caremark.

May 24, 2012

Adherence interventions targeted to nonadherent patients proved more effective in improving medication adherence when compared with broad interventions that cast a wide net to encompass all medication takers, according to new research sponsored by CVS Caremark.

WOONSOCKET, R.I. — Adherence interventions targeted to nonadherent patients proved more effective in improving medication adherence when compared with broad interventions that cast a wide net to encompass all medication takers, according to new research sponsored by CVS Caremark.

According to the study, entitled "Targeting Cardiovascular Medication Adherence Interventions,” more than one-third of adherence interventions targeted to nonadherent patients resulted in improved medication adherence, compared with 18% of broad interventions.

May 23, 2012

Food and Drug Administration drug warnings can have an immediate negative impact on medication adherence among patients, even if the warnings are not safety related, according to new research sponsored by CVS Caremark.

WOONSOCKET, R.I. — Food and Drug Administration drug warnings can have an immediate negative impact on medication adherence among patients, even if the warnings are not safety related, according to new research sponsored by CVS Caremark.

April 17, 2012

Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

March 27, 2012

CVS Caremark issued on Tuesday two new reports that highlight research the company is conducting around medication adherence, including one study that reviews and compares state-by-state adherence rates for patients managing four chronic diseases.


WOONSOCKET, R.I. — CVS Caremark issued on Tuesday two new reports that highlight research the company is conducting around medication adherence, including one study that reviews and compares state-by-state adherence rates for patients managing four chronic diseases.
 

February 23, 2012

Physicians in 35% of cases involving more than 250,000 newly diagnosed diabetes patients did not follow the American Diabetes Association/European Association for the Study of Diabetes consensus guidelines for recommended treatment, according to a new CVS Caremark study.

WOONSOCKET, R.I. — Physicians in 35% of cases involving more than 250,000 newly diagnosed diabetes patients did not follow the American Diabetes Association/European Association for the Study of Diabetes consensus guidelines for recommended treatment, according to a new CVS Caremark study.

December 1, 2011

Schiff Nutrition on Thursday named three new members to its recently established scientific advisory board: Dale Bredesen, Michael Fischbach and Charles Serhan.

SALT LAKE CITY — Schiff Nutrition on Thursday named three new members to its recently established scientific advisory board: Dale Bredesen, Michael Fischbach and Charles Serhan.

October 27, 2011

If employers want to best manage the health and productivity of their employees, they need to continue company-sponsored health plans — that was a key message that Troyen Brennan, EVP and chief medical officer of CVS Caremark, had for attendees at the National Business Group on Health's annual meeting on Thursday.

BOSTON — If employers want to best manage the health and productivity of their employees, they need to continue company-sponsored health plans — that was a key message that Troyen Brennan, EVP and chief medical officer of CVS Caremark, had for attendees at the National Business Group on Health's annual meeting on Thursday.

October 26, 2011

Twenty-four percent of patients given a new medication by their doctor did not fill the prescription, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — Twenty-four percent of patients given a new medication by their doctor did not fill the prescription, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

October 14, 2011

Much as the late Steve Jobs likely did not foresee the iPhone when he and Steve Wozniak hammered away at the Apple I computer, it’s unlikely that Mark Zuckerberg saw the full potential of Facebook when he and a group of friends created it in a Harvard University dormitory.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Much as the late Steve Jobs likely did not foresee the iPhone when he and Steve Wozniak hammered away at the Apple I computer, it’s unlikely that Mark Zuckerberg saw the full potential of Facebook when he and a group of friends created it in a Harvard University dormitory.

(THE NEWS: Study: Online marketing drives 21% in-store sales lift. For the full story, click here.)

October 11, 2011

About half of people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study.

About half of people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a study by researchers at Harvard University, Brigham and Women’s Hospital, and CVS Caremark. Given this, there’s a significant opportunity for pharmacists and doctors to identify and work with caregivers to improve medication adherence and chronic disease management.


October 11, 2011

How much adherence lowers total costs, why some patients do not take their medications as prescribed and whether what’s saved in health care offsets higher drug costs are among the questions that have not been as clearly understood.


Industry members would likely agree that those patients who are adherent to their prescription medications use less health care and have lower overall costs; however, how much adherence lowers total costs, why some patients do not take their medications as prescribed and whether what’s saved in health care offsets higher drug costs are among the questions that have not been as clearly understood.


October 11, 2011

“Dispense-as-written” prescriptions are exacerbating medication nonadherence and costing the U.S. healthcare system up to $7.7 billion annually, according to a study by researchers at Harvard University, Brigham and Women’s Hospital, and CVS Caremark.


“Dispense-as-written” prescriptions are exacerbating medication nonadherence and costing the U.S. healthcare system up to $7.7 billion annually, according to a study by researchers at Harvard University, Brigham and Women’s Hospital, and CVS Caremark.


September 26, 2011

As consumers and patients increasingly use social media as a healthcare tool and resource, a survey by Harvard University, Brigham and Women's Hospital, and CVS Caremark researchers found a need to improve site guidelines, as there is great variability in the standards used to ensure a site effectively provides information and answers to important health-related questions.

WOONSOCKET, R.I. — As consumers and patients increasingly use social media as a healthcare tool and resource, a survey by Harvard University, Brigham and Women's Hospital, and CVS Caremark researchers found a need to improve site guidelines, as there is great variability in the standards used to ensure a site effectively provides information and answers to important health-related questions.

September 12, 2011

While it has been a boon to elderly Americans, Medicare Part D includes a complicating factor that has proven to be a headache.


While it has been a boon to elderly Americans, Medicare Part D includes a complicating factor that has proven to be a headache.


Despite its seemingly charming name, the doughnut hole has proven to be a headache for many seniors. Also known as the Medicare Part D coverage gap, the doughnut hole is when drug costs reach a point when the patient becomes responsible for the entire cost, and Medicare doesn’t pay for them again until they reach the catastrophic-coverage threshold. The hole and threshold change from year to year.


August 17, 2011

Medicare Part D beneficiaries who enter the "doughnut hole," where they have to pay 100% of previously subsidized prescription costs, are twice as likely to discontinue their medications as they are to switch to more affordable or generic medications, according to a new study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — Medicare Part D beneficiaries who enter the "doughnut hole," where they have to pay 100% of previously subsidized prescription costs, are twice as likely to discontinue their medications as they are to switch to more affordable or generic medications, according to a new study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

July 25, 2011

Health care is like precision engineering; tweaking one element ever so slightly can mean the difference between a healthy life and an early death or, in the case of drug spending, between nearly $50,000 and just north of $1,000.


Health care is like precision engineering; tweaking one element ever so slightly can mean the difference between a healthy life and an early death or, in the case of drug spending, between nearly $50,000 and just north of $1,000.


July 7, 2011

Preventive health care may be signficiantly less costly than previously thought because of the expanded use of cost-effective generic medications for the treatment and prevention of chronic diseases, according to researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — Preventive health care may be signficiantly less costly than previously thought because of the expanded use of cost-effective generic medications for the treatment and prevention of chronic diseases, according to researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

June 30, 2011

Drug maker UCB and Harvard University have entered a research alliance that is designed to advance ongoing Harvard research projects along the drug development pathway.

BOSTON and BRUSSELS — Drug maker UCB and Harvard University have entered a research alliance that is designed to advance ongoing Harvard research projects along the drug development pathway.

UCB said it will bring its expertise in antibody generation and medicinal chemistry into the alliance and will provide up to $6 million over two years to fund specific innovative research projects led by Harvard scientists. The collaboration focuses on the central nervous system and immunology, UCB said.